Gilead reportedly settles CDC patent dispute over HIV drugs
Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...
Gilead Sciences, US government settle patent case over HIV prevention drugs
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...
AI IPOs will drive investment bank growth, says portfolio manager
Jay D. Hatfield, CEO of Infrastructure Capital Advisors, says he's "bullish on financials, but more bullish on investment banks," as he expects not only an M&A boom "because of more reasonable ...
Broadcom, Amazon, banks among portfolio manager's 2025 stock picks
Jay D. Hatfield, CEO of Infrastructure Capital Advisors, said strong net interest margins for banks and "AI upside" for tech are why he's bullish on those companies' stocks. Could AI-assisted program ...
Macy's wants Bloomingdale's, Bluemercury to stay put
Macy's CEO Tony Spring, who is trying to turn around the company, wants to prove to the public markets that its three-brand ...